Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDTC Biopharm (Holdings) Plc Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/25/2024 | Q2 2024 | N/A | $0.00 | N/A | N/A | $0 |
| 05/15/2024 | Q1 2024 | N/A | -$0.01 | N/A | N/A | $0 |
| 04/29/2024 | Q4 2023 | N/A | -$0.02 | N/A | N/A | $0 |
| 09/28/2023 | Q3 2023 | N/A | -$0.02 | N/A | N/A | $0 |
| 11/02/2023 | Q2 2023 | N/A | $0.00 | N/A | N/A | $0 |
| 11/02/2023 | Q1 2023 | N/A | -$0.02 | N/A | N/A | $0 |
| 05/01/2023 | Q4 2022 | N/A | -$0.07 | N/A | N/A | $1.43 M |
| 09/28/2022 | Q3 2022 | N/A | -$0.07 | N/A | N/A | $1.43 M |
| 12/12/2022 | Q2 2022 | N/A | $0.00 | N/A | N/A | $494,665 |
| 03/30/2022 | Q1 2022 | N/A | $0.00 | N/A | N/A | $494,665 |
| 05/13/2022 | Q4 2021 | N/A | -$0.50 | N/A | N/A | $494,665 |
| 09/30/2021 | Q3 2021 | N/A | -$0.86 | N/A | N/A | $494,664 |
| 06/29/2021 | Q2 2021 | N/A | $0.00 | N/A | N/A | $494,665 |
| 03/30/2021 | Q1 2021 | N/A | $0.00 | N/A | N/A | $494,665 |
| 12/31/2020 | Q4 2020 | N/A | -$0.16 | N/A | N/A | $494,665 |
| 09/28/2020 | Q3 2020 | N/A | -$0.14 | N/A | N/A | $494,664 |
| 06/29/2020 | Q2 2020 | N/A | $0.00 | N/A | N/A | $494,665 |
| 03/30/2020 | Q1 2020 | N/A | $0.00 | N/A | N/A | $494,665 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
TC Biopharm (Holdings) Plc Earnings: FAQ's
The conference call for TC Biopharm (Holdings) Plc's latest earnings report can be listened to online.
The conference call transcript for TC Biopharm (Holdings) Plc's latest earnings report can be read online.
TC Biopharm (Holdings) Plc (:TCBPW) has a recorded net income of $-5,906,953.TC Biopharm (Holdings) Plc has generated $-0.0478025 earnings per share over the last four quarters.
TC Biopharm (Holdings) Plc (:TCBPW) has a price-to-earnings ratio of -0.73 and price/earnings-to-growth ratio is 0.09.